The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors

Table 2

Clinical and laboratory characteristics of the ET patients included in the study.

Patients characteristics
Number of patients	233
Median follow-up (months)	48.4 (range 0.3–313)
Median age at diagnosis (years)	65.9 (range 14.5–92)
Age <60 years	87 (37.3%)
Age >60 years	146 (62.7%)
Female	160 (68.7%)
Male	73 (31.3%)
1 CVR	92 (39.5%)
>1 CVR	82 (35.2%)
JAK2 V617F positive/tested	168/233 (72.1% of the total number of pts)
CALR mutated/tested	21/65 (9% of the total number of pts)
MPL mutated/tested	4/44 (1.7% of the total number of pts)
Triple negative	40 (17.2% of the total number of pts)
Thrombosis before or at diagnosis	48 (20.6%)
Thrombosis after diagnosis	14 (6%)